ResearcherVanderbilt UniversityActive in the last 2 years
Qiuyin Cai
Matched on ORCID iD 0000-0002-9384-5648; OpenAlex author ID A5005513706, A5013793540. Sources: OpenAlex.
Their work
- Papers
- 8 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 46
2016: 1 paper · 2017: 1 paper · 2018: none · 2019: none · 2020: 1 paper · 2021: 1 paper · 2022: 1 paper · 2023: 1 paper · 2024: 1 paper · 2025: none · 2026: 1 paper
Papers 8
- Dynamics of the association between circulating levels of miRNA and pancreatic cancer risk through the years prior to pancreatic cancer diagnosis. Co-author DOI 10.1002/ijc.70452↗
- Circulating microRNAs in association with pancreatic cancer risk within 5 years. Co-author DOI 10.1002/ijc.34956↗
- Urine biomarkers enable pancreatic cancer detection up to 2 years before diagnosis. Co-author DOI 10.1002/ijc.34287↗
- The oral microbiome in relation to pancreatic cancer risk in African Americans. Co-author DOI 10.1038/s41416-021-01578-5↗
- Integrating Genome and Methylome Data to Identify Candidate DNA Methylation Biomarkers for Pancreatic Cancer Risk. Co-author DOI 10.1158/1055-9965.epi-21-0400↗
- Associations between Genetically Predicted Blood Protein Biomarkers and Pancreatic Cancer Risk. Co-author DOI 10.1158/1055-9965.epi-20-0091↗
- Prospective study of urinary prostaglandin E2 metabolite and pancreatic cancer risk. Co-author DOI 10.1002/ijc.31007↗
- A prospective study of autoantibodies to Ezrin and pancreatic cancer risk. Last author DOI 10.1007/s10552-016-0757-y↗
Closest collaborators
The 25 strongest of 46 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Xiao‐Ou Shu · 7 shared papers, 2017–2026 · strength 1.03
- Paper Dynamics of the association between circulating levels of miRNA and pancreatic cancer risk through the years prior to p… DOI 10.1002/ijc.70452↗
- Paper Circulating microRNAs in association with pancreatic cancer risk within 5 years. DOI 10.1002/ijc.34956↗
- Paper Urine biomarkers enable pancreatic cancer detection up to 2 years before diagnosis. DOI 10.1002/ijc.34287↗
- Hui Cai · 4 shared papers, 2016–2026 · strength 0.72
- Paper Dynamics of the association between circulating levels of miRNA and pancreatic cancer risk through the years prior to p… DOI 10.1002/ijc.70452↗
- Paper Circulating microRNAs in association with pancreatic cancer risk within 5 years. DOI 10.1002/ijc.34956↗
- Paper Urine biomarkers enable pancreatic cancer detection up to 2 years before diagnosis. DOI 10.1002/ijc.34287↗
- Rachael Z. Stolzenberg‐Solomon · 3 shared papers, 2020–2026 · strength 0.54
- Paper Dynamics of the association between circulating levels of miRNA and pancreatic cancer risk through the years prior to p… DOI 10.1002/ijc.70452↗
- Paper Circulating microRNAs in association with pancreatic cancer risk within 5 years. DOI 10.1002/ijc.34956↗
- Paper Associations between Genetically Predicted Blood Protein Biomarkers and Pancreatic Cancer Risk. DOI 10.1158/1055-9965.epi-20-0091↗
- Veronica Wendy Setiawan · 2 shared papers, 2024–2026 · strength 0.47
- Fei Ye · 2 shared papers, 2024–2026 · strength 0.47
- Jordan D. Berlin · 2 shared papers, 2024–2026 · strength 0.47
- Wei Zheng · 4 shared papers, 2017–2024 · strength 0.43
- Paper Circulating microRNAs in association with pancreatic cancer risk within 5 years. DOI 10.1002/ijc.34956↗
- Paper Integrating Genome and Methylome Data to Identify Candidate DNA Methylation Biomarkers for Pancreatic Cancer Risk. DOI 10.1158/1055-9965.epi-21-0400↗
- Paper Associations between Genetically Predicted Blood Protein Biomarkers and Pancreatic Cancer Risk. DOI 10.1158/1055-9965.epi-20-0091↗
- Jirong Long · 3 shared papers, 2020–2022 · strength 0.31
- Paper The oral microbiome in relation to pancreatic cancer risk in African Americans. DOI 10.1038/s41416-021-01578-5↗
- Paper Integrating Genome and Methylome Data to Identify Candidate DNA Methylation Biomarkers for Pancreatic Cancer Risk. DOI 10.1158/1055-9965.epi-21-0400↗
- Paper Associations between Genetically Predicted Blood Protein Biomarkers and Pancreatic Cancer Risk. DOI 10.1158/1055-9965.epi-20-0091↗
- Yu‐Tang Gao · 2 shared papers, 2017–2024 · strength 0.25
- Dominique S. Michaud · 2 shared papers, 2021–2022 · strength 0.24
- Cong Wang · 1 shared paper, 2024 · strength 0.19
- Silvana Debernardi · 1 shared paper, 2023 · strength 0.18
- Kirtiman Srivastava · 1 shared paper, 2023 · strength 0.18
- Christie Y. Jeon · 1 shared paper, 2023 · strength 0.18
- Tatjana Crnogorac‐Jurcevic · 1 shared paper, 2023 · strength 0.18
- Oleg B. Blyuss · 1 shared paper, 2023 · strength 0.18
- Lang Wu · 2 shared papers, 2020–2021 · strength 0.18
- Xiang Shu · 2 shared papers, 2020–2021 · strength 0.18
- Jingjing Zhu · 2 shared papers, 2020–2021 · strength 0.18
- Duo Liu · 2 shared papers, 2020–2021 · strength 0.18
- Julie R Palmer · 1 shared paper, 2022 · strength 0.13
- Jessica L. Petrick · 1 shared paper, 2022 · strength 0.13
- Hanna Gerlovin · 1 shared paper, 2022 · strength 0.13
- Brian Matthew Wolpin · 1 shared paper, 2022 · strength 0.13
- Douglas W. Mahoney · 1 shared paper, 2021 · strength 0.11
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.